Starting today, eligible customers can access a broad assortment of treatment options, including the only FDA-approved GLP-1 weight loss pill Hims & Hers Health, Inc
Currently approved options include: Semaglutide: Available as a weekly injection (Ozempic for type 2 diabetes, Wegovy for weight management) or a daily oral tablet (Rybelsus for type 2 diabetes)
On the other hand, Wegovy (brand name for semaglutide), approved by FDA recently for chronic weight management along with dietary changes and physical activity, has shown substantial efficacy in reducing body weight as it influences eating patterns centrally leading to decreased calorie intake
How to switch safely If youre considering switching, always discuss this with your prescriber first
More applications from Sandoz, Teva Canada and others are under Health Canada review, which should push prices lower still as they launch through 2026
Ozempic is a GLP-1 receptor agonist used to treat type 2 diabetes, along with diet and exercise